Har­poon CEO re­signs in wake of dwin­dling mar­ket cap and slid­ing stock price

Bleed­ing mar­ket cap since the start of June, Har­poon Ther­a­peu­tics has found it­self in the midst of a CEO tran­si­tion.

Jer­ry McMa­hon is re­sign­ing from his pres­i­dent and chief ex­ec­u­tive posts, Har­poon an­nounced af­ter the clos­ing bell Tues­day, as the com­pa­ny hopes to move past a months-long slide that’s seen $HARP shares fall near­ly 70%. McMa­hon will be suc­ceed­ed by Julie East­land, the COO and CFO of Re­Code Ther­a­peu­tics, ef­fec­tive Nov. 8.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER